Obesity and consequent changes in the body

Bojana Kisić Orcid logo ,
Bojana Kisić
Dragana Puhalo-Sladoje ,
Dragana Puhalo-Sladoje
Dijana Mirić Orcid logo ,
Dijana Mirić
Dragiša Rašić ,
Dragiša Rašić
Tatjana Novaković
Tatjana Novaković

Published: 01.12.2021.

Volume 51, Issue 3 (2022)

pp. 35-43;

https://doi.org/10.5937/pramed2204035k

Abstract

Obesity is one of the most common chronic, non-infectious diseases in the world and our country, and it is characterized by excessive accumulation of fat tissue in the body and an increase in body weight. The increase in the number of obese people is an important global health problem. Obesity is associated with cardiometabolic and psychosocial comorbidities, and may also affect years of healthy life and reduce life expectancy. Numerous factors, such as biological predisposition, socioeconomic factors and environmental factors, interact and influence the development and maintenance of obesity. Excess adipose tissue in the body and its dysfunction is associated with inflammation and increased risk of metabolic, mechanical and mental complications. It is very important to monitor the incidence of obesity and its impact on the development of chronic non-communicable diseases and life expectancy due to the development and implementation of strategies to prevent the increase in the number of obese people.

Keywords

References

1.
Suren Garg S, Kushwaha K, Dubey R, Gupta J. Association between obesity, inflammation and insulin resistance: Insights into signaling pathways and therapeutic interventions. Diabetes Research and Clinical Practice. 2023;200:110691.
2.
Powell-Wiley TM, Poirier P, Burke LE, Després JP, Gordon-Larsen P, Lavie CJ, et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021;143(21).
3.
Koenen M, Hill MA, Cohen P, Sowers JR. Obesity, Adipose Tissue and Vascular Dysfunction. Circulation Research. 2021;128(7):951–68.
4.
Clayton TL, Fitch A, Bays HE. Obesity and hypertension: Obesity medicine association (OMA) clinical practice statement (CPS) 2023. Obesity Pillars. 2023;8:100083.
5.
Parvanova A, Reseghetti E, Abbate M, Ruggenenti P. Mechanisms and treatment of obesity-related hypertension—Part 1: Mechanisms. Clinical Kidney Journal. 2024;17(1).

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by